The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AMBER parts 1c and 1e: A phase 1 study of cobolimab plus dostarlimab in patients (pts) with advanced/metastatic melanoma.
 
Antoni Ribas
Leadership - Arcus Biosciences; Lutris; PACT Pharma
Stock and Other Ownership Interests - 4c Biomed; Advaxis; Appia Bio; Arcus Biosciences; Compugen; CytomX Therapeutics; Highlight Therapeutics; ImaginAb; ImmPACT-Bio; Inspirna; Isoplexis; Kite/Gilead; Lutris; MapKure; Merus; PACT Pharma; Pluto Immunotherapeutics; RAPT Therapeutics; Synthekine; Tango Therapeutics
Honoraria - Amgen; AstraZeneca; Chugai/Roche; Genentech/Roche; Merck Sharp & Dohme; Novartis; Sanofi; Vedanta Biosciences
Consulting or Advisory Role - Amgen; Chugai Pharma; Merck; Novartis; Sanofi
Research Funding - Agilent (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Non-viral gene editing to Arsenal Bio
 
Zeynep Eroglu
Consulting or Advisory Role - Elsevier; Genentech/Roche; Natera; Novartis; OncoSec; Regeneron; Sun Pharma
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Jose Manuel Manuel Trigo Perez
Consulting or Advisory Role - BMS; Boehringer Ingelheim; Merck Serono; Takeda
Speakers' Bureau - AstraZeneca; Merck Serono; MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca; BMS; MSD Oncology
 
Brian Di Pace
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Tianli Wang
Employment - GlaxoSmithKline; Pfizer (I)
Stock and Other Ownership Interests - GlaxoSmithKline; Pfizer (I)
Patents, Royalties, Other Intellectual Property - Abbvie
 
Srimoyee Ghosh
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Arindam Dhar
Employment - GlaxoSmithKline; PRA Health Sciences (I); PurpleLab (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb (I); GlaxoSmithKline; GlaxoSmithKline (I); PRA Health Sciences (I)
 
Theo Borgovan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Angela Waszak
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Diwakar Davar
Honoraria - Array BioPharma; Immunocore; Instil Bio; Merck; Tesaro; Vedanta Biosciences
Consulting or Advisory Role - Instil Bio; Shionogi (I); Vedanta Biosciences
Research Funding - Arcus Biosciences; CellSight Technologies; Checkmate Pharmaceuticals; GlaxoSmithKline; Merck; Merck; Zucero Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Application No.: 63/124,231; Enteric Microbiotype Signatures of Immune-related Adverse Events and Response in Relation to Anti-PD-1 Immunotherapy